Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Granules India Ltd.
NSE: GRANULES
|
BSE: 532482
|
ISIN: INE101D01020
|
Industry: Pharmaceuticals
US FDA Approval
|
Strong Performer, Getting Expensive
600.7500
17.35
(
2.97
%)
NSE
Dec 22, 2025
15:31 PM
Near 52W High of ₹621.10
Volume:
1.8M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Granules India Ltd.
24 Nov 2022
US FDA Approval
600.75
2.97%
GRANULES INDIA
Accumulate:
Granules India Ltd.
by
Geojit BNP Paribas
Target: 408
Target
Geojit BNP Paribas
Granules India Ltd. has an
average target
of 632.00 from 4 brokers.
More from Granules India Ltd.
Recommended
IPO market stays hot this week with KSH International's listing and eleven new issues
|
22 Dec 2025, 05:22PM
Market closes higher amid foreign investor inflows & rupee stabilization
Trendlyne Marketwatch |
22 Dec 2025, 04:09PM
Granules: Will the record-breaking numbers sustain for this API pharmaceutical company?
|
30 Oct 2020